                               SEQUENCE LISTING

<110> REGENTS OF THE UNIVERSITY OF MINNESOTA
 
<120> ANTI-DR5 POLYPEPTIDES AND METHODS OF USE THEREOF

<130> 09531-506WO1

<140> PCT/US2021/020719
<141> 2021-03-03

<150> 62/985,105
<151> 2020-03-04

<160> 44    

<170> PatentIn version 3.5

<210> 1
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Glu Gln Gly Tyr Ala Gly Arg Glu Ile Arg Leu 
1               5                   10      


<210> 2
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Glu Lys Leu Asp Ala Tyr Pro Val Ile Glu Asp 
1               5                   10      


<210> 3
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Glu Arg Glu Phe Ala Val Leu Glu Ile Ser Leu 
1               5                   10      


<210> 4
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Glu Gly Glu Val Ala Gly Ala Glu Ile Thr Val 
1               5                   10      


<210> 5
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Glu Ser Thr Leu Ala Glu Ile Glu Ile Leu Arg 
1               5                   10      


<210> 6
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Glu Asp Tyr Leu Ala Val Val Glu Ile Val Gly 
1               5                   10      


<210> 7
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Pro Gln Gly Gly Ala Phe Ile Gly Ala Leu Ala Asp 
1               5                   10          


<210> 8
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Glu Gln Val Met Ala Phe Ile Val Ala Leu Glu Asn 
1               5                   10          


<210> 9
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Val Gln Ser Leu Ala Phe Ile Pro Ala Leu Gly Asp 
1               5                   10          


<210> 10
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Gly Gln Ala Gly Ala Phe Ile Gln Ala Leu Leu Asp 
1               5                   10          


<210> 11
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Ala Gln Ile Tyr Ala Phe Ile Leu Ala Leu Thr Asp 
1               5                   10          


<210> 12
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Gly Gln Thr Leu Ala Phe Ile Phe Ala Leu Gly Asp 
1               5                   10          


<210> 13
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Ser Glu Leu Leu Ser Glu Ala Lys Lys Leu Asn Asp Ser 
1               5                   10              


<210> 14
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Ala Asn Leu Leu Ala Glu Ala Lys Lys Leu Asn Asp Ala 
1               5                   10              


<210> 15
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Ala Glu Ala Lys Tyr Ala Lys 
1               5           


<210> 16
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Val Asp Asn Lys Phe Asn Lys 
1               5           


<210> 17
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Leu Pro Asn Leu Thr Asn 
1               5       


<210> 18
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Leu Pro Asn Leu Thr Arg 
1               5       


<210> 19
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Leu Pro Asn Leu Thr Leu 
1               5       


<210> 20
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Leu Pro Asn Leu Thr Asp 
1               5       


<210> 21
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Leu Pro Asn Leu Thr Cys 
1               5       


<210> 22
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Leu Pro Asn Leu Asn Glu 
1               5       


<210> 23
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Leu Pro Asn Leu Asn Trp 
1               5       


<210> 24
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Leu Pro Asn Leu Asn Val 
1               5       


<210> 25
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 25
Leu Pro Asn Leu Asn Asn 
1               5       


<210> 26
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Asp Pro Asn Leu Asn Asn 
1               5       


<210> 27
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Asp Pro Ser Gln Ser 
1               5   


<210> 28
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Gln Ala Pro Lys 
1               


<210> 29
<211> 58
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 29
Ala Glu Ala Lys Tyr Ala Lys Glu Gln Gly Tyr Ala Gly Arg Glu Ile 
1               5                   10                  15      


Arg Leu Leu Pro Asn Leu Thr Arg Pro Gln Gly Gly Ala Phe Ile Gly 
            20                  25                  30          


Ala Leu Ala Asp Asp Pro Ser Gln Ser Ser Glu Leu Leu Ser Glu Ala 
        35                  40                  45              


Lys Lys Leu Asn Asp Ser Gln Ala Pro Lys 
    50                  55              


<210> 30
<211> 58
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 30
Ala Glu Ala Lys Tyr Ala Lys Glu Lys Leu Asp Ala Tyr Pro Val Ile 
1               5                   10                  15      


Glu Asp Leu Pro Asn Leu Thr Leu Glu Gln Val Met Ala Phe Ile Val 
            20                  25                  30          


Ala Leu Glu Asn Asp Pro Ser Gln Ser Ser Glu Leu Leu Ser Glu Ala 
        35                  40                  45              


Lys Lys Leu Asn Asp Ser Gln Ala Pro Lys 
    50                  55              


<210> 31
<211> 58
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 31
Ala Glu Ala Lys Tyr Ala Lys Glu Arg Glu Phe Ala Val Leu Glu Ile 
1               5                   10                  15      


Ser Leu Leu Pro Asn Leu Thr Asp Val Gln Ser Leu Ala Phe Ile Pro 
            20                  25                  30          


Ala Leu Gly Asp Asp Pro Ser Gln Ser Ser Glu Leu Leu Ser Glu Ala 
        35                  40                  45              


Lys Lys Leu Asn Asp Ser Gln Ala Pro Lys 
    50                  55              


<210> 32
<211> 58
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 32
Ala Glu Ala Lys Tyr Ala Lys Glu Gly Glu Val Ala Gly Ala Glu Ile 
1               5                   10                  15      


Thr Val Leu Pro Asn Leu Thr Cys Gly Gln Ala Gly Ala Phe Ile Gln 
            20                  25                  30          


Ala Leu Leu Asp Asp Pro Ser Gln Ser Ser Glu Leu Leu Ser Glu Ala 
        35                  40                  45              


Lys Lys Leu Asn Asp Ser Gln Ala Pro Lys 
    50                  55              


<210> 33
<211> 58
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 33
Ala Glu Ala Lys Tyr Ala Lys Glu Ser Thr Leu Ala Glu Ile Glu Ile 
1               5                   10                  15      


Leu Arg Leu Pro Asn Leu Thr Asn Ala Gln Ile Tyr Ala Phe Ile Leu 
            20                  25                  30          


Ala Leu Thr Asp Asp Pro Ser Gln Ser Ser Glu Leu Leu Ser Glu Ala 
        35                  40                  45              


Lys Lys Leu Asn Asp Ser Gln Ala Pro Lys 
    50                  55              


<210> 34
<211> 58
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 34
Ala Glu Ala Lys Tyr Ala Lys Glu Asp Tyr Leu Ala Val Val Glu Ile 
1               5                   10                  15      


Val Gly Leu Pro Asn Leu Thr Leu Gly Gln Thr Leu Ala Phe Ile Phe 
            20                  25                  30          


Ala Leu Gly Asp Asp Pro Ser Gln Ser Ser Glu Leu Leu Ser Glu Ala 
        35                  40                  45              


Lys Lys Leu Asn Asp Ser Gln Ala Pro Lys 
    50                  55              


<210> 35
<211> 174
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 35
gccgaagcaa aatacgctaa agaacagggg tatgcggggc gtgaaatcag gctgctgccg       60

aacctgaccc ggcctcaggg gggtgcattc ataggggcac tggctgatga cccgtcccag      120

agctctgaac tcctgtctga ggcgaagaaa ctgaacgatt cccaagcacc aaaa            174


<210> 36
<211> 174
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 36
gccgaagcaa aatacaacaa agaaaagttg gacgcgtacc ccgtgatcga ggacctgccg       60

aacctgaccc tcgagcaggt gatggcattc atcgtggcac tggagaacga cccgtcccag      120

agctctgaac tcctgtctga ggcgaagaaa ctgaacgatt cccaagcacc aaaa            174


<210> 37
<211> 174
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 37
gccgaagcga aatacgctaa agaacgggag tttgcggttt tggaaatcag tttgctgccg       60

aacctgaccg atgtgcagag tttggcattc atacctgcac tgggtgatga cccgtcccag      120

agctctgaac tcctgtctga ggcgaagaaa ctgaacgatt cccaagcacc aaaa            174


<210> 38
<211> 174
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 38
gccgaagcga aatacgctaa agaaggggag gtggcggggg cggaaatcac ggttctgccg       60

aacctgacct gtgggcaggc gggggcattc atacaggcac tgctggatga cccgtcccag      120

agctctgaac tcctgtctga ggcgaagaaa ctgaacgatt cccaagcacc aaag            174


<210> 39
<211> 174
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 39
gccgaagcaa aatacgctaa agaatctacg ttggcggaga ttgaaatcct gcgtctgccg       60

aacctgacca atgcgcagat ttatgcattc atacttgcac tgactgatga cccgtcccag      120

agctctgaac tcctgtctga ggcgaagaaa ctgaacgatt cccaagcacc aaaa            174


<210> 40
<211> 174
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 40
gccgaagcaa aatacgctaa agaagattat ttggcggtgg tggaaatcgt ggggctgccg       60

aacctgaccc ttggtcagac tctggcattc atatttgcac tgggtgatga cccgtcccag      120

agctctgaac tcctgtctga ggcgaagaaa ctgaacgatt cccaagcacc aaaa            174


<210> 41
<211> 58
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 41
Ala Glu Ala Lys Tyr Asn Lys Glu Lys Leu Asp Ala Tyr Pro Val Ile 
1               5                   10                  15      


Glu Asp Leu Pro Asn Leu Thr Leu Glu Gln Val Met Ala Phe Ile Val 
            20                  25                  30          


Ala Leu Glu Asn Asp Pro Ser Gln Ser Ser Glu Leu Leu Ser Glu Ala 
        35                  40                  45              


Lys Lys Leu Asn Asp Ser Gln Ala Pro Lys 
    50                  55              


<210> 42
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 42
Ala Glu Ala Lys Tyr Asn Lys 
1               5           


<210> 43
<211> 58
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      wild-type affibody

<400> 43
Ala Glu Ala Lys Tyr Ala Lys Glu Met Arg Asn Ala Tyr Trp Glu Ile 
1               5                   10                  15      


Ala Leu Leu Pro Asn Leu Thr Asn Gln Gln Lys Arg Ala Phe Ile Arg 
            20                  25                  30          


Lys Leu Tyr Asp Asp Pro Ser Gln Ser Ser Glu Leu Leu Ser Glu Ala 
        35                  40                  45              


Lys Lys Leu Asn Asp Ser Gln Ala Pro Lys 
    50                  55              


<210> 44
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6xHis tag

<400> 44
His His His His His His 
1               5       


